Patents by Inventor Loïc TOMAS

Loïc TOMAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CARBOHYDRATE CROSSLINKER
    Publication number: 20260022214
    Abstract: The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.
    Type: Application
    Filed: February 26, 2025
    Publication date: January 22, 2026
    Applicant: Galderma Holding SA
    Inventors: Hotan MOJARRADI, Johan OLSSON, Craig HARRIS, Jean-Guy BOITEAU, Thibaut GERFAUD, Loïc TOMAS
  • SYNTHESIS OF CHIRAL SUBSTITUTED PYRAZOLOPYRIMIDINE COMPOUNDS
    Publication number: 20240294532
    Abstract: The present invention relates to processes and intermediates for the preparation of compounds useful as inhibitors of mechanistic target of rapamycin (mTOR).
    Type: Application
    Filed: January 11, 2024
    Publication date: September 5, 2024
    Applicant: Galderma Holding S.A.
    Inventors: Loïc TOMAS, Craig Steven HARRIS
  • CARBOHYDRATE CROSSLINKER
    Publication number: 20230416469
    Abstract: The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.
    Type: Application
    Filed: September 5, 2023
    Publication date: December 28, 2023
    Applicant: Galderma Holding SA
    Inventors: Hotan MOJARRADI, Johan OLSSON, Craig Steven HARRIS, Jean-Guy BOITEAU, Thibaut GERFAUD, Loïc TOMAS
  • Carbohydrate crosslinker
    Patent number: 11780970
    Abstract: The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.
    Type: Grant
    Filed: March 15, 2023
    Date of Patent: October 10, 2023
    Assignee: GALDERMA HOLDING S.A.
    Inventors: Hotan Mojarradi, Johan Olsson, Craig Harris, Jean-Guy Boiteau, Thibaut Gerfaud, Loïc Tomas
  • Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitors
    Patent number: 11731973
    Abstract: The invention relates to novel mTOR inhibitor compounds having the formula (I) or a pharmaceutically acceptable salt thereof, compositions comprising the mTOR inhibitor compounds, methods for producing the same, and the use thereof.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: August 22, 2023
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Laurence Clary, Jean-François Fournier, Gilles Ouvry, Yushma Bhurruth-Alcor, Etienne Thoreau, Loïc Tomas
  • CARBOHYDRATE CROSSLINKER
    Publication number: 20230212360
    Abstract: The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.
    Type: Application
    Filed: March 15, 2023
    Publication date: July 6, 2023
    Applicant: Galderma Holding SA
    Inventors: Hotan MOJARRADI, Johan OLSSON, Craig HARRIS, Jean-Guy BOITEAU, Thibaut GERFAUD, Loïc TOMAS
  • Carbohydrate crosslinker
    Patent number: 11643509
    Abstract: The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.
    Type: Grant
    Filed: November 29, 2022
    Date of Patent: May 9, 2023
    Assignee: Galderma Holding SA
    Inventors: Hotan Mojarradi, Johan Olsson, Craig Steven Harris, Jean-Guy Boiteau, Thibaut Gerfaud, Loïc Tomas
  • CARBOHYDRATE CROSSLINKER
    Publication number: 20230102832
    Abstract: The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.
    Type: Application
    Filed: November 29, 2022
    Publication date: March 30, 2023
    Applicant: Galderma Holding SA
    Inventors: Hotan MOJARRADI, Johan OLSSON, Craig Steven HARRIS, Jean-Guy BOITEAU, Thibaut GERFAUD, Loïc TOMAS
  • Carbohydrate crosslinker
    Patent number: 11530301
    Abstract: The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: December 20, 2022
    Assignee: Galderma Holding SA
    Inventors: Hotan Mojarradi, Johan Olsson, Craig Steven Harris, Jean-Guy Boiteau, Thibaut Gerfaud, Loïc Tomas
  • MTOR inhibitor compounds
    Patent number: 11518767
    Abstract: The invention relates to novel mTOR inhibitor compounds having the general formula (I), to compositions comprising said mTOR inhibitor compounds, methods for producing same, and the use thereof in compositions as a drug.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: December 6, 2022
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Laurence Clary, Jean-François Fournier, Gilles Ouvry, Yushma Bhurruth-Alcor, Etienne Thoreau, Loïc Tomas
  • MTOR INHIBITOR COMPOUNDS
    Publication number: 20200317683
    Abstract: The invention relates to novel mTOR inhibitor compounds. The invention is characterized in that the mTOR inhibitor compounds have general formula (I). The invention also relates to compositions comprising said mTOR inhibitor compounds, methods for producing same, and the use thereof in compositions as a drug.
    Type: Application
    Filed: June 19, 2020
    Publication date: October 8, 2020
    Inventors: Laurence CLARY, Jean-François FOURNIER, Gilles OUVRY, Yushma BHURRUTH-ALCOR, Etienne THOREAU, Loïc TOMAS
  • NOVEL MTOR INHIBITOR COMPOUNDS
    Publication number: 20200317679
    Abstract: The invention relates to novel mTOR inhibitor compounds. The invention is characterized in that the mTOR inhibitor compounds have general formula (I). The invention also relates to compositions comprising said mTOR inhibitor compounds, methods for producing same, and the use thereof in compositions as a drug.
    Type: Application
    Filed: June 19, 2020
    Publication date: October 8, 2020
    Inventors: Laurence CLARY, Jean-François FOURNIER, Gilles OUVRY, Yushma BHURRUTH-ALCOR, Etienne THOREAU, Loïc TOMAS
  • CARBOHYDRATE CROSSLINKER
    Publication number: 20190023812
    Abstract: The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.
    Type: Application
    Filed: December 28, 2016
    Publication date: January 24, 2019
    Applicant: GALDERMA S.A.
    Inventors: Hotan MOJARRADI, Johan OLSSON, Craig Steven HARRIS, Jean-Guy BOITEAU, Thibaut GERFAUD, Loïc TOMAS